No Data
No Data
No Data
No Data
No Data
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
BenzingaApr 30 01:04
Enlivex Therapeutics: Promising Trial Results for Allocetra
TipRanksApr 29 21:31
HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $7 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Enlivex Therapeutics with a Buy and maintains $7 price target.
Analyst UpgradesApr 23 18:33
Enlivex Announces Dosing Of First Two Patients In Its Randomized, Controlled Phase I/II Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
Enlivex Therapeutics Ltd. (NASDAQ:ENLV, the "Company"))))), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the first two patients have been dosed in the Company'
BenzingaApr 22 20:05
Enlivex Announces Authorization From Danish Medicines Agency For A Randomized, Controlled Phase I/II Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
Enlivex Announces Authorization From Danish Medicines Agency For A Randomized, Controlled Phase I/II Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
BenzingaApr 16 19:57
Will Enlivex Therapeutics (NASDAQ:ENLV) Spend Its Cash Wisely?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose mo
Simply Wall StApr 16 19:15
No Data
No Data